The Freeland File
Global Market Data
Tales from the Trail
Lucy P. Marcus
David Cay Johnston
The Great Debate
Macro & Markets
Personal Finance Video
RIM and BlackBerry on the edge under new CEO
Consumers ask for experimental drugs cover
Tracking microclimates could help feed the world
Tablet, e-reader ownership double over holidays
Weaker sun will not delay global warming
Korean research, a step toward Dr. Smartphone?
Huge pool of Arctic water could cool Europe: study
Great Debate: Keystone XL’s organizing principle
Video: "Smart E-book" turns page on technology
Slideshow: Wildfire in Nevada
Subculture of Americans prepares for civilization's collapse
21 Jan 2012
Senator Paul refuses airport patdown after
Romney puts Gingrich on defensive before debate
Iran slams EU oil embargo and warns could hit U.S.
Russia alarmed by EU ban on Iranian oil, sanctions
Subculture of Americans prepares for civilization’s collapse
Supreme Court rejects judge-drawn Texas election maps
Obama set to reject Keystone oil pipeline: sources
Angelina Jolie fascinated by "bizarre" Republican presidential race
Sun, Jan 22 2012
New footage shows dangers faced by Italian police rescue divers
Sat, Jan 21 2012
A dangerous walk to school
Fri, Jan 20 2012
Korean research, a first step toward Dr. Smartphone?
Samsung Group plans record $41 billion investment in 2012
Tue, Jan 17 2012
Day in the life of a fund manager in Las Vegas
Thu, Jan 12 2012
Insight: New DNA reader to bring promise
Tue, Jan 10 2012
Cancer rates in U.S. keep falling: American Cancer Society
Thu, Jan 5 2012
A customer tries Samsung Electronics' Galaxy smartphone at a store in Seoul January 17, 2012.
Credit: Reuters/Kim Hong-Ji
Mon Jan 23, 2012 12:38pm EST
SEOUL (Reuters) - Tired of long waits at the hospital for medical tests? If Korean researchers have their way, your smartphone could one day eliminate that -- and perhaps even tell you that you have cancer.
A team of scientists at Korea Advanced Institute of Science of Technology (KAIST) said in a paper published in Angewandte Chemie, a German science journal, that touch screen technology can be used to detect biomolecular matter, much as is done in medical tests.
"It began from the idea that touch screens work by recognizing the electronic signs from the touch of the finger, and so the presence of specific proteins and DNA should be recognizable as well," said Hyun-gyu Park, who with Byong-yeon Won led the study.
The touch screens on smartphones, PDAs or other electronic devices work by sensing the electronic charges from the user's body on the screen. Biochemicals such as proteins and DNA molecules also carry specific electronic charges.
According to KAIST, the team's experiments showed that touch screens can recognize the existence and the concentration of DNA molecules placed on them, a first step toward one day being able to use the screens to carry out medical tests.
"We have confirmed that (touch screens) are able to recognize DNA molecules with nearly 100 percent accuracy just as large, conventional medical equipment can and we believe equal results are possible for proteins," Park told Reuters TV.
"There are proteins known in the medical world like the ones used to diagnose liver cancer, and we would be able to see the liver condition of the patient."
The research team added that it is currently developing a type of film with reactive materials that can identify specific biochemicals, hoping this will allow the touch screens to also recognize different biomolecular materials.
But confirming that the touch screen can recognize the biomolecular materials, though key, is only the first step.
Since nobody would put blood or urine on a touch screen, the sample would be placed on a strip, which would then be fed into the phone or a module attached to the phone through what Park called an "entrance point."
"The location and concentration of the sample would be recognized the same way the touch of the finger is recognized," he added.
There are no details yet on a prospective timetable for making the phone a diagnostic tool, however.
SOURCE: bit.ly/tuxZ6V Angewandte Chemie, January 16, 2012.
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Be the first to comment on reuters.com.
Add yours using the box above.
Back to top
New York Legal
Support & Contact
Advertise With Us
Connect with Reuters
Our Flagship financial information platform incorporating Reuters Insider
An ultra-low latency infrastructure for electronic trading and data distribution
A connected approach to governance, risk and compliance
Our next generation legal research platform
Our global tax workstation
About Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.